Table 2. Patient characteristics.
| Total* (n=34) | Sustained Complete Response (n=6) | Recurrence (n=28) | p-value | |
|---|---|---|---|---|
| Age [years] | 67±9 | 67±9 | 67±9 | 0.570 |
| Female, n (%) | 11 (32) | 5 (83) | 6 (21) | 0.008 |
| BMI [kg/m2] | 29±5 | 27±4 | 29±6 | 0.371 |
| Symptoms, n (%) | ||||
| Splenomegaly | 26 (76) | 3 (50) | 23 (82) | 0.126 |
| Ascites | 5 (15) | 1 (16) | 5 (15) | 0.998 |
| Varices | 24 (71) | 4 (67) | 20 (71) | 0.997 |
| Child-Pugh, n (%) | ||||
| A | 30 (91) | 6 (100) | 24 (89) | 0.999 |
| B | 2 (0) | 0 (0) | 2 (6) | 0.999 |
| C | 1 (0) | 0 (0) | 1 (3) | 0.999 |
| MELD score | 10±2 | 8±2 | 10±2 | 0.080 |
| Multiple nodules | 14 (41) | 2 (33) | 12 (43) | 0.176 |
| Etiology, n (%) | ||||
| HCV related | 23 (67) | 4 (67) | 19 (67) | 0.999 |
| NASH related | 4 (11) | 1 (17) | 3 (10) | 0.558 |
| Alcohol related | 4 (11) | 0 (0) | 4 (14) | 0.998 |
| Others | 3 (9) | 1 (16) | 2 (7) | 0.452 |
| Platelet count [thou/mm3] | 99 (68-147) | 102 (61-107) | 106 (99-146) | 0.838 |
| INR* | 1.17±0.13 | 1.08±0.09 | 1.19±0.13 | 0.031 |
| Albumin (g/dL) | 3.7±0.4 | 4.2±0.2 | 3.7±0.5 | 0.049 |
| Total bilirubin (mg/dL) | 1.1 (0.6-2.2) | 0.6 (0.4-0.9) | 1.3 (0.7-2.4) | 0.025 |
| Alpha-fetoprotein (ng/mL) | 26 (5-101) | 20 (3-53) | 26 (6-122) | 0.378 |
BMI: body mass index; MELD: model for end-stage liver disease.
*
Plus-minus values are means±SD.